CYTK — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

13.34

Margin Of Safety %

Put/Call OI Ratio

0.19

EPS Next Q Diff

0.05

EPS Last/This Y

0.76

EPS This/Next Y

1.53

Price

56.12

Target Price

109.42

Analyst Recom

1.22

Performance Q

-24.24

Upside

-476.4%

Beta

0.48

Ticker: CYTK

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	CYTK	63.49	0.15	0.06	82484
2026-10-15	CYTK	63.92	0.15	0.73	83236
2026-10-16	CYTK	61.97	0.14	2.85	82944
2026-10-19	CYTK	62.7	0.14	0.46	78632
2026-10-20	CYTK	63.89	0.14	0.03	79463
2026-10-21	CYTK	62.89	0.14	36.31	80265
2026-10-22	CYTK	62.28	0.17	0.22	82010
2026-10-23	CYTK	61.2	0.17	2.87	82004
2026-10-26	CYTK	60.77	0.17	0.08	81960
2026-10-27	CYTK	61.65	0.17	0.02	82063
2026-10-28	CYTK	61.3	0.17	0.03	82525
2026-10-29	CYTK	63.34	0.17	0.07	82267
2026-10-30	CYTK	63.01	0.17	0.69	82343
2026-11-02	CYTK	62.05	0.17	0.10	82351
2026-11-03	CYTK	62.59	0.17	0.00	82355
2026-11-04	CYTK	64.32	0.17	0.20	82382
2026-11-05	CYTK	55.71	0.17	4.74	82472
2026-11-06	CYTK	53.69	0.18	0.73	83566
2026-11-09	CYTK	55.12	0.18	0.22	83583
2026-11-10	CYTK	56.21	0.18	0.20	86335
2026-11-11	CYTK	58.54	0.17	0.63	87329
2026-11-12	CYTK	56.13	0.19	0.00	89062
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	CYTK	63.44	7.3	-	-5.94
2026-10-15	CYTK	63.94	7.3	-	-5.94
2026-10-16	CYTK	61.97	7.3	-	-5.94
2026-10-19	CYTK	62.68	7.3	-	-5.94
2026-10-20	CYTK	62.68	7.3	-	-5.94
2026-10-21	CYTK	63.95	8.3	-	-5.88
2026-10-22	CYTK	62.31	8.4	-	-5.87
2026-10-23	CYTK	61.22	8.4	-	-5.87
2026-10-26	CYTK	60.75	8.5	-	-5.87
2026-10-27	CYTK	61.66	8.8	-	-5.88
2026-10-28	CYTK	61.32	8.8	-	-5.88
2026-10-29	CYTK	63.32	8.8	-	-5.88
2026-10-30	CYTK	63.03	8.8	-	-5.88
2026-11-02	CYTK	62.12	8.8	-	-5.88
2026-11-03	CYTK	62.35	8.8	-	-5.88
2026-11-04	CYTK	64.42	8.8	-	-5.88
2026-11-05	CYTK	55.89	8.8	-	-5.88
2026-11-06	CYTK	53.69	7.4	-	-5.88
2026-11-09	CYTK	55.13	7.4	-	-5.88
2026-11-10	CYTK	56.24	6.0	-	-5.99
2026-11-11	CYTK	58.52	9.7	-	-5.78
2026-11-12	CYTK	56.12	9.7	-	-5.78
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	CYTK	-8.33	10.94	14.41
2026-10-15	CYTK	-8.33	10.94	14.41
2026-10-16	CYTK	-8.07	10.94	14.41
2026-10-19	CYTK	-8.07	11.09	14.41
2026-10-20	CYTK	-8.07	11.09	14.41
2026-10-21	CYTK	-8.13	11.09	14.41
2026-10-22	CYTK	-8.07	11.09	14.41
2026-10-23	CYTK	-8.07	11.09	14.41
2026-10-26	CYTK	-8.07	10.68	14.41
2026-10-27	CYTK	-8.07	10.68	13.89
2026-10-28	CYTK	-8.07	10.68	13.89
2026-10-29	CYTK	-8.07	10.68	13.89
2026-10-30	CYTK	-7.94	10.68	13.89
2026-11-02	CYTK	-7.68	10.61	13.89
2026-11-03	CYTK	-7.81	10.61	13.89
2026-11-05	CYTK	-7.60	10.61	13.89
2026-11-06	CYTK	-6.48	10.61	13.89
2026-11-09	CYTK	-6.47	9.82	13.86
2026-11-10	CYTK	-6.47	9.82	13.86
2026-11-11	CYTK	-6.47	9.82	13.34
2026-11-12	CYTK	-6.47	9.82	13.34
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.37

Avg. EPS Est. Current Quarter

-1.35

Avg. EPS Est. Next Quarter

-1.32

Insider Transactions

-6.47

Institutional Transactions

9.82

Beta

0.48

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

49.1

Max Drawdown 5-Year %

-72.4

Target Price

109.42

P/E

Forward P/E

PEG

P/S

69.06

P/B

P/Free Cash Flow

EPS

-6.04

Average EPS Est. Cur. Y

-5.78

EPS Next Y. (Est.)

-4.25

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-686.63

Relative Volume

0.9

Return on Equity vs Sector %

215.8

Return on Equity vs Industry %

235.3

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.17

EBIT Estimation

◆ CYTK Healthcare

$56.16

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

12/25

Volume

4/15

Valuation

12/20

TP/AR

2/10

Options

8/10

RSI

38.2

Range 1M

22.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

21/30

Estimates

1/20

Inst/Vol

6/15

Options

8/10

EPS Yr

8.6%

EPS NY

27.8%

52W%

7.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +94.8% upside

Quality

7/30

Valuation

15/30

Growth

15/25

Stability

9/10

LT Trend

1/5

Upside

+94.8%

Quality

CYTK — P/E HistoricalBiotechnology

Cytokinetics, Incorporated

Sector: Healthcare

Industry: Biotechnology

Employees: 673

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

CYTK

Latest News

—

Caricamento notizie per CYTK…

stock quote shares CYTK – Cytokinetics, Incorporated Stock Price stock today

news today CYTK – Cytokinetics, Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch CYTK – Cytokinetics, Incorporated yahoo finance google finance

stock history CYTK – Cytokinetics, Incorporated invest stock market

stock prices CYTK premarket after hours

ticker CYTK fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CYTK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y